Immediate Impact
3 by Nobel laureates 3 from Science/Nature 93 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Fibroblasts in cancer: Unity in heterogeneity
2023 Standout
Works of Thomas A. Chiodo being referenced
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Thomas A. Chiodo | 59 | 8 | 115 | 135 | 89 | 8 | 342 | |
| Yasser El-Gohary | 75 | 7 | 177 | 100 | 157 | 12 | 405 | |
| Mahmut Celiker | 39 | 26 | 110 | 126 | 116 | 12 | 329 | |
| R. J. Sanderson | 122 | 2 | 107 | 55 | 72 | 14 | 363 | |
| Katiuscia O’Brian | 51 | 3 | 136 | 54 | 97 | 13 | 373 | |
| Michael Kellick | 90 | 10 | 100 | 41 | 80 | 12 | 389 | |
| Doreen L. Wiggins | 56 | 8 | 150 | 103 | 87 | 16 | 380 | |
| Anne‐Chantal Braud | 164 | 1 | 114 | 152 | 94 | 10 | 407 | |
| Francisco G. Pernas | 124 | 1 | 80 | 47 | 122 | 8 | 395 | |
| Garrett Barry | 106 | 1 | 110 | 163 | 129 | 11 | 400 | |
| Kayla Morrell | 116 | 2 | 63 | 71 | 67 | 16 | 319 |
All Works
Loading papers...